Nitto Avecia competitors

Zippia score 4.2

Nitto Avecia main competitors are Sarepta Therapeutics, Amgen, and CytoSorbents.

Competitor Summary. See how Nitto Avecia compares to its main competitors:

Amgen has the most employees (22,000).
Employees at Sarepta Therapeutics earn more than most of the competitors, with an average yearly salary of $94,985.

Work at Nitto Avecia?

Share your experience

Nitto Avecia vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Nitto Avecia	-	4.2	Milford, MA	1	$27.3M	471
Cytovance Biologics	2003	4.3	Oklahoma City, OK	1	$12.0M	261
Avrio Biopharmaceuticals	2008	3.6	Irvine, CA	1	$3.2M	125
Renmatix	2007	4.3	King of Prussia, PA	3	$15.0M	48
Moderna	2010	4.8	Cambridge, MA	2	$3.2B	2,500
Amgen	1980	4.8	Thousand Oaks, CA	9	$33.4B	22,000
Cambridge Major Laboratories, Inc.	-	3.5	Germantown, WI	1	$17.0M	200
Sarepta Therapeutics	1980	4.8	Cambridge, MA	2	$1.9B	840
Gelest	1991	4.1	Morrisville, PA	1	$26.8M	50
CytoSorbents	1997	3.9	Monmouth Junction, NJ	2	$35.6M	160
CIMA Labs	1986	3.9	Eden Prairie, MN	1	$8.5M	120

Rate Nitto Avecia's competitiveness in the market.

Nitto Avecia salaries vs competitors

Among Nitto Avecia competitors, employees at Sarepta Therapeutics earn the most with an average yearly salary of $94,985.

Compare Nitto Avecia salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Nitto Avecia	$75,882	$36.48	-
Cytovance Biologics	$73,328	$35.25	-
Avrio Biopharmaceuticals	$73,019	$35.11	-
Renmatix	$47,508	$22.84	-
Moderna	$81,825	$39.34	-
Amgen	$93,349	$44.88	-

Compare Nitto Avecia job title salaries vs competitors

Company	Highest salary	Hourly salary
Nitto Avecia	$83,586	$40.19
CytoSorbents	$102,290	$49.18
CIMA Labs	$86,516	$41.59
Sarepta Therapeutics	$85,625	$41.17
Amgen	$80,918	$38.90
Cambridge Major Laboratories, Inc.	$76,348	$36.71
Moderna	$70,091	$33.70
Cytovance Biologics	$69,207	$33.27
Renmatix	$61,455	$29.55
Gelest	$58,960	$28.35
Avrio Biopharmaceuticals	$58,892	$28.31

Do you work at Nitto Avecia?

Does Nitto Avecia effectively differentiate itself from competitors?

Nitto Avecia jobs

Nitto Avecia demographics vs competitors

Compare gender at Nitto Avecia vs competitors

Job title	Male	Female
Sarepta Therapeutics	44%	56%
CytoSorbents	53%	47%
Amgen	57%	43%
Moderna	61%	39%
Gelest	90%	10%
Nitto Avecia	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Nitto Avecia vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Amgen	49%	24%	7%	15%	5%	9.7
CytoSorbents	52%	11%	13%	22%	2%	6.1
Sarepta Therapeutics	66%	12%	5%	13%	4%	9.3
Moderna	56%	13%	8%	21%	3%	9.0
Gelest	55%	15%	8%	21%	2%	6.1

Nitto Avecia and similar companies CEOs

CEOBio

Robert A. Bradway

Amgen

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Douglas S. Ingram

Sarepta Therapeutics

Douglas 'Doug' Ingram is a CEO and President at SAREPTA THERAPEUTICS, INC.; Board Member at SAREPTA THERAPEUTICS, INC.; and Board Member at Relay Therapeutics Inc and is based in Irvine, California. He has worked as Assistant General Counsel at Actavis, President at Actavis, and Board Member at Volcom. Douglas works or has worked as BOARD MEMBER at Allergan Foundation and Board Member at Pacific Life. He studied at James E Rogers College of Law until 1988, Arizona State University between 1980 and 1985, and University of Arizona.

Wang Yan

Cytovance Biologics

Wang Yan are a Chief Executive Officer at Cytovance Biologics, President at Scientific Protein Labs Llc, and Board Member at Cytovance Biologics. They have worked as VP:Business Development at Scientific Protein Labs Llc.

Stephan Kutzer

Cambridge Major Laboratories, Inc.

Stephan Kutzer is a Chief Executive Officer at aaiPharma Inc and Chief Executive Officer at Cambridge Major Laboratories Inc. He has worked as COO:Pharma & Biotech Mkt Segment at Lonza America Inc., Head:Performance Chemicals at Lonza America Inc., and Site Manager:Bayport at Lonza America Inc.. Stephan studied at Technische Universitaet Muenchen.

Michael Hamilton

Renmatix

Mike Hamilton is a Chief Executive Officer at Renmatix and Director:Asia Pacific at Rohm And Haas Co. and is based in Atlanta, Georgia. He has worked as Director:Investor Relations at Rohm And Haas Co.. Mike studied at Western University between 1989 and 1991 and Western University between 1983 and 1988.

Stephane Bancel

Moderna

Stéphane Bancel (born 1972) is a French billionaire businessman. He is the chief executive officer (CEO) and a 9% owner of Moderna, an American biotechnology company.

Ken Gayer

Gelest

Ken Gayer is a Chief Executive Officer at Gelest Inc.. He has experience at PRIMARY PDC INC and McKinsey & Company and has worked as Pres:Specialty Products at Honeywell International Inc., VP & Gen Mgr:Fluorine Products at Honeywell International Inc., and VP:Procurement & Customer Service at Honeywell International Inc..

Assad Chi

Avrio Biopharmaceuticals